Search
-
What’s keeping us from making our food supply chain better?
How will the supply chain evolve to address the tensions between our ‘on-demand’ economy and conflicting desire for sustainability, for locally-pro¬duced, but also cheap and accessible food? Ipsos interviews Marina Mayer, editor-in-chief of both Food Logistics and Supply & Demand Chain Executive magazines, on where she thinks the supply chain is headed.
-
The Evolution of the American Identity
The way Americans understand the legacy of racism influences how they view corporate communication and action around the issue. Here’s a few tips.
-
Health
As our nation ages and a caregiver shortage looms, will technology be able to bridge the gap? We ask experts from IBM/Watson, MIT, and the Milken Institute to explore “big questions” that companies should be asking about the future of their industries.
-
The State of Reputation: Today’s Context; Tomorrow’s Expectations
Hear corporate reputation research insights exploring the impacts of COVID, Diversity and Inclusion, ESG, Internal Communications, Supply Chain issues, and more.
-
Insights For Pharma: Helping ‘Challenger’ Brands Win
Discover tips for how a “challenger” brand can make a mark, and ultimately win at launch...
-
Biden's Build Back Better framework is supported by over half of Americans
Seven out of ten Americans or more support expanded Medicare coverage, universal preschool, and other components of Biden's Build Back Better framework
-
Empathy Awakened: The power of an empathetic organization
Discover why empathy is essential for your business - not the purely emotional kind but the one that includes purposeful action and delivery.
-
How can high-end brands redefine luxury shopping for the digital age?
Nearly a quarter of luxury shoppers prefer to shop online versus in-store, and nearly 4-in-10 prefer both online and in-store equally.
-
Oncology: the disease, dynamics & challenges of market research
The oncology treatment landscape rarely stands still, and its constant evolution affects all those involved: patients, their carers, cancer treaters, and treatment manufactures.